Your browser doesn't support javascript.
loading
Echinacoside exerts its protective effects in a type 2 diabetes mellitus injury model via the AKT pathway.
Ye, Wei-Wei; Meng, Xiang-Ying; Zhao, Qian; Chen, Jian-Yang; Liu, Cong; Chen, Feng; Zhou, Yong; Wang, Yi.
Afiliação
  • Ye WW; Department of Endocrinology, Dahua Hospital, Shanghai 200237, China.
  • Meng XY; Department of Endocrinology, Dahua Hospital, Shanghai 200237, China.
  • Zhao Q; Department of Endocrinology, Dahua Hospital, Shanghai 200237, China.
  • Chen JY; Department of Endocrinology, Dahua Hospital, Shanghai 200237, China.
  • Liu C; Department of Endocrinology, Dahua Hospital, Shanghai 200237, China.
  • Chen F; Department of Endocrinology, Dahua Hospital, Shanghai 200237, China.
  • Zhou Y; Department of Endocrinology, Dahua Hospital, Shanghai 200237, China.
  • Wang Y; Department of Endocrinology, Dahua Hospital, Shanghai 200237, China.
J Asian Nat Prod Res ; 25(9): 880-889, 2023 Sep.
Article em En | MEDLINE | ID: mdl-36573490
ABSTRACT
Echinacoside (ECH) is the main compound of Cistanche deserticola, which possesses antioxidant, antitumor, antifatigue, and anti-inflammatory properties. The present study investigated the protective effects of echinacoside on type 2 diabetes mellitus (T2DM)-induced injury in T2DM injury db/db mice model and insulin-resistant LO2 cell model. The results demonstrated that ECH probably alleviated T2DM-induced injury by mediating the AKT pathway, which provided a new direction for the treatment of T2DM-induced injury.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article